Vuno signed a clinical research contract with Harvard Medical School Massachusetts General Hospital (MGH) to evaluate the performance of VUNO Med-LungCT AI, an artificial intelligence-based chest computed tomography (CT) image reading assistance solution.The device is a solution that automatically d
Classys, a skincare device maker, announced that CEO Jung Sung-jae and related parties have agreed to transfer 39.41 million shares (60.84 percent) and management rights to Bain Capital for 669.9 billion won ($556.7 million).After the transfer of the holdings, CEO Jung and affiliated persons will co
PCL, a Korean diagnostic device maker, said Thursday it signed an agreement with Austrian pharmaceutical companies Haemo Pharma GmbH and Sanochemia to establish an RT-PCR test center in Austria.The official name of the center is Sanochemia Labor GmbH.PCL, Haemo Pharma, and Sanochemia will purchase f
AbbVie said its drug Skyrizi (ingredient: risankizumab) obtained the U.S. FDA authorization to treat adults with active psoriatic arthritis (PsA).The FDA approval was based on the results of the KEEPsAKE-1 and KEEPsAKE-2 trials which tested Skyrizi in adults with PsA, including those who had respond
Hanmi Pharmaceutical is busy preparing for a market release of inhaled asthma medication, Glyterol Inhalation Cap. 110/50 μg.As the original drug's patent expired partially, industry officials are closely watching when Hanmi will release Glyterol.The Ministry of Food and Drug Safety said Hanmi’s Gly
After 14 months of collaboration, SK Chemicals and Dr. Noah Biotech succeeded in deriving three new drug candidates to treat nonalcoholic steatohepatitis (NASH) and idiopathic pulmonary fibrosis (IDF) using artificial intelligence.The two companies stressed that their results have proved AI technolo
Celltrion and Icure Pharmaceutical have registered a pharmaceutical patent on a “patch-type dementia treatment,” preparing to release the product in Korea within the first half of this year.The Ministry of Food and Drug Safety (MFDS) said the two companies registered the patent on the donepezil-cont
The government started implementing a new virus response system as the nation marked a new record-high figure in daily infection cases.On Wednesday, the Korea Disease Control and Prevention Agency (KDCA) confirmed 13,012 new virus cases, including 12,743 local infections, raising the cumulative case
Hugel said that the EU's Heads of Medicines Agencies (HMA) has issued a positive opinion for the approval of Letybo, its botulinum toxin (BTX) product, for treating forehead wrinkles.HMA is an association of drug safety management organizations in each European country.The company expects to enter i
The Ministry of Food and Drug Safety (MFDS) decided to prohibit the use of dye compound 1,2,4-trihydroxybenzene (1,2,4-THB) contained in MODA MODA’s shampoo.Upon the decision, the company may have to suspend making and selling its product, Pro-change Black Shampoo.On Wednesday, the MFDS said that as
A Korean research team developed a biosensor platform that can detect the Covid-19 virus in 20 minutes regardless of the type of variants. Its sensitivity is as high as PCR testing.On Wednesday, the Korea Institute of Science and Technology (KIST) said that the research team led by Drs. Lee Kwan-hyi
Eutilex signed an MOU with Medirama, specializing in clinical consulting, to develop and commercialize strategic new drugs.The two companies will maximize synergy in the overall development of new drugs, such as discovering additional candidates for Eutilex’s cell therapy and dual antibody therapy,
A joint research team of three Korean hospitals has found that rhythm control therapy could lower the risk of dementia in patients with atrial fibrillation.Atrial fibrillation is the most common arrhythmia that requires treatment, showing symptoms such as palpitations, tightness or dizziness, and sh
Lung cancer patients want the reimbursement of new drugs and the introduction of a system to lower the treatment cost, according to a survey.Korea Cancer Society, a cancer patient support group, made these and other points while releasing the results of its survey on 286 lung cancer patients at a we
The digital pathology market is emerging as a new growth industry after an AI product in digital pathology received the first-ever FDA approval in September last year.The global digital pathology market is forming mainly in the U.S. and Europe, and the Korean government and companies should consider
The government is considering lowering the eligible age for oral Covid-19 treatments from 60 to 50, Prime Minister Kim Boo-kyum said on Tuesday.“About 200 patients who had taken the Covid-19 pills so far showed definite improvements,” Kim said after presiding over a Cabinet meeting. “If patients tak
Kyongbo Pharm said Tuesday it recently obtained approval from the Ministry of Food and Drug Safety for DPP-4 antidiabetic drugs Vilda Tab. and Vildamet Tab.Four products got the marketing approval – one monotherapy using vildagliptin as the main ingredient and three doses of Vilda Tab. plus metformi
As Korea’s new Covid-19 cases keep breaking records day by day amid the spread of the Omicron variant, experts called for the nation to work out a response system that can control the massive outbreaks of infections.According to the Central Disaster and Safety Countermeasures Headquarters, new virus
NeoImmuneTech said it released preclinical results of NT-I7 in mouse models of glioblastoma (GBM) in Clinical Cancer Research, a major oncology journal published by the American Association for Cancer Research (AACR).NeoImmuneTech is developing NT-I7 as a T cell amplifier immunotherapy.The preclinic
Discontinuation of an immunosuppressant (azathioprine), one of the two major treatments, does not affect clinical relapse of Crohn’s disease in pediatric patients, a study said.The study came as great news for Crohn’s disease patients who have to receive treatments for a lifetime.Crohn's disease is